A peptide antagonist disrupts NK cell inhibitory synapse formation

J Immunol. 2013 Mar 15;190(6):2924-30. doi: 10.4049/jimmunol.1201032. Epub 2013 Feb 4.

Abstract

Productive engagement of MHC class I by inhibitory NK cell receptors depends on the peptide bound by the MHC class I molecule. Peptide:MHC complexes that bind weakly to killer cell Ig-like receptors (KIRs) can antagonize the inhibition mediated by high-affinity peptide:MHC complexes and cause NK cell activation. We show that low-affinity peptide:MHC complexes stall inhibitory signaling at the step of Src homology protein tyrosine phosphatase 1 recruitment and do not go on to form the KIR microclusters induced by high-affinity peptide:MHC, which are associated with Vav dephosphorylation and downstream signaling. Furthermore, the low-affinity peptide:MHC complexes prevented the formation of KIR microclusters by high-affinity peptide:MHC. Thus, peptide antagonism of NK cells is an active phenomenon of inhibitory synapse disruption.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Mutation
  • Peptides / antagonists & inhibitors*
  • Peptides / metabolism
  • Phenylalanine / genetics
  • Protein Binding / genetics
  • Protein Binding / immunology
  • Receptors, KIR2DL3 / genetics
  • Receptors, KIR2DL3 / metabolism
  • Signal Transduction / immunology
  • Synapses / immunology*
  • Synapses / metabolism

Substances

  • KIR2DL3 protein, human
  • Peptides
  • Receptors, KIR2DL3
  • Phenylalanine